2021
DOI: 10.1016/s1473-3099(20)30769-6
|View full text |Cite|
|
Sign up to set email alerts
|

Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis

Abstract: Background As the COVID-19 pandemic continues to unfold, the infection-fatality risk (ie, risk of death among all infected individuals including those with asymptomatic and mild infections) is crucial for gauging the burden of death due to COVID-19 in the coming months or years. Here, we estimate the infection-fatality risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City, NY, USA, the first epidemic centre in the USA, where the infection-fatality risk remains unclear.Methods In… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

28
204
1
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 186 publications
(261 citation statements)
references
References 20 publications
28
204
1
2
Order By: Relevance
“… 4 , 5 , 6 , 7 , 8 However, most studies do not have a representative sample or separate out special populations, such as those in nursing homes. 5 , 9 Moreover, infection fatality rate is not an inherent characteristic of the disease, but rather a confluence of the pathogen virulence, sociodemographic and clinical characteristics of the population, health care availability and quality, therapeutic availability, and accurate counting and reporting of COVID-19-related deaths. As such, an overall infection fatality rate may not be very informative given the heterogeneity across regions.…”
Section: Discussionmentioning
confidence: 99%
“… 4 , 5 , 6 , 7 , 8 However, most studies do not have a representative sample or separate out special populations, such as those in nursing homes. 5 , 9 Moreover, infection fatality rate is not an inherent characteristic of the disease, but rather a confluence of the pathogen virulence, sociodemographic and clinical characteristics of the population, health care availability and quality, therapeutic availability, and accurate counting and reporting of COVID-19-related deaths. As such, an overall infection fatality rate may not be very informative given the heterogeneity across regions.…”
Section: Discussionmentioning
confidence: 99%
“…In March 2020, the World Health Organization (WHO) and Centers for Disease Control (CDC) declared a pandemic for the coronavirus, Severe acute respiratory syndrome (SARS-CoV-2) also known as coronavirus disease or COVID-19. Indeed, the case fatality ratio for those over 75 years old is 14.2%, while for those that are younger even by just 10 years, that number is significantly less at 4.87% [5]. The high fatality ratio of COVID-19 for those over 75 years old highlights the need for improved vaccine responses as part of a multifaceted approach to healthy aging.…”
Section: Introductionmentioning
confidence: 99%
“…IDR scenarios Although still debated, studies agree that IDR increases with age, and some studies estimate IDR can be as low as 10% for youngsters and 40% for the elderly even in wealthy cities, within wealthy countries as is the case of New York 12 . In this context, three IDR scenarios were considered, all with a symptomatic proportion of total infections corresponding to Poletti s results 16 .…”
Section: Methodsmentioning
confidence: 99%
“…However, this issue has been scarcely documented and noted by the community, even though infection detection rates are estimated to be below 12% for most countries, and 16% or less even for developed countries such as the United States of America, Canada, China, Sweden and The United Kingdom 11 . Accordingly, an analysis for the city of New York estimates an IDR of 15-20% 12 . Undetected infections are a key characteristic of the COVID-19 pandemic that severely impacts CT strategies, as no contact tracing is possible without diagnosis, which is most generally triggered by symptom onset.…”
Section: Introductionmentioning
confidence: 99%